Close

AbbVie's (ABBV) Glecaprevir/Pibrentasvir HCV Regiment Receives FDA Breakthrough Therapy Designation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. BIIB


Go back to AbbVie's (ABBV) Glecaprevir/Pibrentasvir HCV Regiment Receives FDA Breakthrough Therapy Designation
AbbVie (NYSE: ABBV) Delayed: 167.29 -0.51 (0.3%)
Previous Close $167.80    52 Week High $68.12 
Open $167.66    52 Week Low $50.71 
Day High $169.29    P/E 36.29 
Day Low $165.57    EPS $4.61 
Volume 5,450,091       

ENANTA PHARM (NASDAQ: ENTA) Delayed: 12.48 -0.44 (3.41%)
Previous Close $12.92    52 Week High $34.49 
Open $12.62    52 Week Low $20.39 
Day High $12.74    P/E N/A 
Day Low $12.40    EPS $-3.18 
Volume 79,696